Beta-caryophyllene is a dietary cannabinoid

Top Cited Papers
Publisher Website
Google Scholar
Abstract
The psychoactive cannabinoids fromCannabis sativaL. and the arachidonic acid-derived endocannabinoids are nonselective natural ligands for cannabinoid receptor type 1 (CB1) and CB2receptors. Although the CB1receptor is responsible for the psychomodulatory effects, activation of the CB2receptor is a potential therapeutic strategy for the treatment of inflammation, pain, atherosclerosis, and osteoporosis. Here, we report that the widespread plant volatile (E)-β-caryophyllene [(E)-BCP] selectively binds to the CB2receptor (Ki= 155 ± 4 nM) and that it is a functional CB2agonist. Intriguingly, (E)-BCP is a common constituent of the essential oils of numerous spice and food plants and a major component inCannabis. Molecular docking simulations have identified a putative binding site of (E)-BCP in the CB2receptor, showing ligand π–π stacking interactions with residues F117 and W258. Upon binding to the CB2receptor, (E)-BCP inhibits adenylate cylcase, leads to intracellular calcium transients and weakly activates the mitogen-activated kinases Erk1/2 and p38 in primary human monocytes. (E)-BCP (500 nM) inhibits lipopolysaccharide (LPS)-induced proinflammatory cytokine expression in peripheral blood and attenuates LPS-stimulated Erk1/2 and JNK1/2 phosphorylation in monocytes. Furthermore, peroral (E)-BCP at 5 mg/kg strongly reduces the carrageenan-induced inflammatory response in wild-type mice but not in mice lacking CB2receptors, providing evidence that this natural product exerts cannabimimetic effectsin vivo. These results identify (E)-BCP as a functional nonpsychoactive CB2receptor ligand in foodstuff and as a macrocyclic antiinflammatory cannabinoid inCannabis.